首页 | 本学科首页   官方微博 | 高级检索  
     


The landscape of somatic mutations in Indonesian cervical cancer is predominated by the PI3K pathway
Authors:Vivian M. Spaans  I. Nyoman Bayu Mahendra  Gatot Purwoto  Marjolijn D. Trietsch  Michelle Osse  Natalja ter Haar  Alexander A.W. Peters  Gert J. Fleuren  Ekaterina S. Jordanova
Affiliation:1. Department of Obstetrics and Gynecology, Leiden University Medical Center, Leiden, The Netherlands;2. Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands;3. Department of Obstetrics and Gynecology, Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia;4. Department of Gynecology and Obstetrics, Faculty of Medicine, University of Indonesia, Rumah Sakit Dr. Cipto Mangunkusumo, Jakarta, Java, Indonesia;5. Center for Gynecologic Oncology, Amsterdam, The Netherlands
Abstract:

Objective

To investigate the prevalence of somatic mutations in Indonesian cervical carcinoma patients in the context of histology and human papillomavirus (HPV) type.

Methods

In total 174 somatic hot-spot mutations in 13 genes were analyzed by mass spectrometry in 137 Indonesian cervical carcinomas.

Results

In 66/137 tumors (48%) 95 mutations were identified. PIK3CA was most frequently mutated (24%), followed by FBXW7 (7%), CTNNB1 (6%), and PTEN (6%). In squamous cell carcinomas more often multiple mutations per sample (p = 0.040), and more PIK3CA (p = 0.039) and CTNNB1 (p = 0.038) mutations were detected compared to adenocarcinomas. PIK3CA mutations were associated with HPV 16 positivity, CDKN2A mutations with HPV 52 positivity, and, interestingly, PTEN mutations with HPV negativity. Balinese tumor samples more often carried multiple mutations (p = 0.019), and more CTNNB1, CDKN2A, and NRAS mutations compared to Javanese tumor samples.

Conclusions

Potentially targetable somatic mutations occurred in 48% of Indonesian cervical carcinomas. The landscape of mutations is predominated by mutations concerning the PI3K pathway, and we prompt for more research on developing therapies targeting this pathway, explicitly for the more advanced stage cervical carcinoma patients.
Keywords:Cervical carcinoma  somatic mutation  Indonesia  human papillomavirus  cancer genomics  targeting therapy
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号